Chemosensitizing steroids: Glucocorticoid receptor agonists capable of inhibiting P-glycoprotein function

Cancer Research

Volumn 57, Issue 4, 1997, Pages 720-727

  Gruol, Donald J ^a   Bourgeois, Suzanne ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN P;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CHEMOSENSITIVITY; DRUG EFFICACY; ENZYME INHIBITION; HORMONE TRANSPORT; LYMPHOID CELL; MOUSE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN TRANSPORT; STEROID METABOLISM;

ADOLESCENT; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; DAUNORUBICIN; DEXAMETHASONE; FEASIBILITY STUDIES; HUMANS; MICE; MICE, INBRED BALB C; P-GLYCOPROTEIN; PREDNISOLONE; PROGESTERONE; RECEPTORS, GLUCOCORTICOID; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0031058658     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gros, P., and Buschman, E. The mouse multidrug resistance gene family: structural and functional analysis. Int. Rev. Cytol., 137C: 169-197, 1993.
2. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
3. Germann, U. A. P-glycoprotein-A mediator of multidrug resistance in tumor cells. Eur. J. Cancer, 32A: 927-944, 1996.
4. Licht, T., Pastan, I., Gottesman, M. M., and Herrmann, F. P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. Ann. Hematol., 69: 159-171, 1994.
5. Ling, V. P-glycoprotein: its role in drug resistance. Am. J. Med., 99(Suppl): 31S-34S, 1995.
6. Nelson, E. J., and Hinkle, P. A. Characterization of multidrug-resistant pituitary tumor cells. Endocrinology, 130: 3246-3256, 1992.
7. Ueda, K., Okamura, N., Hira, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., and Hori, R. Human P-glycoprotein transports cortisol, aldosterone, and dexametnasone, but not progesterone. J. Biol. Chem., 267: 24248-24252, 1992.
8. Wolf, D. C., and Band Horwitz, S. P-glycoprotein transports corticosterone and is photoaffmity-labeled by the steroid. Int. J. Cancer, 52: 141-146, 1992.
9. Bourgeois, S., Gruol, D. J., Newby, R. F., and Rajah, F. M. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol. Endocrinol., 7: 840-851, 1993.
10. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84: 265-269, 1987.
11. De Vita, V. T., Jr., Hubbard, S. M., and Longo, D. L. The chemotherapy of lymphomas: looking back, moving forward. Cancer Res., 47: 5810-5824, 1987.
12. Urba, W. J., Duffey, P. L., and Longo, D. L. Treatment of patients with aggressive lymphomas: an overview. J. Natl. Cancer Inst. Monogr., 10: 29-37, 1990.
13. Marie, J-P., Zittoun, R., and Sikic, B. I. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood, 78: 586-592, 1991.
14. Dalton, W., and Sikic, B. I. The multidrug-resistance gene (MDR1) represents a potential target for reversing drug resistance in human malignancies. J. NIH Res., 6: 54-58, 1994.
15. Ivy, S. P., Olshefski, R. S., Taylor, B. J., Patel, K. M., and Rearman, G. H. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study. Blood, 88: 309-316, 1996.
16. Yang, C-P. H., Goei DePinho, S., Greenberger, L. M., Arceci, R. J., and Band Horwitz, S. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J. Biol. Chem., 264: 782-788, 1989.
17. Yang, C-P. H., Cohen, D., Greenberger, L. M., Hsu, S. I-H., and Band Horwitz, S. Differential transport properties of two mdr gene products are distinguished by progesterone. J, Biol. Chem., 265: 10282-10288, 1990.
18. Qian, X-d., and Beck, W. T. Progesterone photoaffmity labels P-glycoprotein in multidrug-resistant human leukemic lymphoblasts. J. Biol. Chem., 265: 18753-18756, 1990.
19. Gruol, D. J., Zee, M. C., Trotter, J., and Bourgeois, S. Reversal of multidrug resistance by RU486. Cancer Res., 54: 3088-3091, 1994.
20. Lecureur, V., Fardel, O., and Guillouzo, A. The antiprogestatin drug RU486 potentiates doxorubicin cytotoxicity in multidnig resistant cells through inhibition of P-glycoprotein function. FEBS Lett., 355: 187-191, 1994.
21. Gruol, D. J., and Bourgeois, S. Expression of the mdr1 P-glycoprotein: a mechanism of escape from glucocorticoid-induced apoptosis, Biochem. Cell Biol., 72: 561-571, 1994.
22. Harris, A. W., Bankhurst, A. D., Mason, S., and Wamer, N. L. Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor on cells of a thymoma cell line. J. Immunol., 110: 431-438, 1973.
23. Johnson, D. M., Newby, R. F., and Bourgeois, S. Membrane permeability as a determinant of dexamethasone resistance in murine thymoma cells. Cancer Res., 44: 2435-2440, 1984.
24. Gruol, D. J., and Dalton, D. K. Phenothiazines cause a shift in the cAMP dose-response: selection of resistant variants in a murine thymoma line. J. Cell. Physiol., 119: 107-118, 1984.
25. Beck, W. T., Mueller, T. J., and Tanzer, L. R. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res., 39: 2070-2076, 1979.
26. Gruol, D. J., Rajah, F. M., and Bourgeois, S. Cyclic AMP-dependent protein kinase modulation of the glucocorticoid-induced cytolytic response in murine T-lymphoma cells. Mol. Endocrinol., 3: 2119-2127, 1989.
27. Bech-Hansen, N. T., Till, J. E., and Ling, V. Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity. J. Cell. Physiol., 88: 23-32, 1976,
28. Juliano, R. L., and Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455: 152-162, 1976.
29. Ayesh, S., Shao, Y-M., and Stein, W. D. Co-operative, competitive and noncompetitive interactions between modulators of P-glycoprotein. Biochim. Biophys. Acta, 1316: 8-18, 1996.
30. Futscher, B. W., Foley, N. E., Gleason-Gutzman, M. C., Meltzer, P. S., Sullivan, D. M., and Dalton, W. S. Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance. Int. J. Cancer, 66: 520-525, 1996.
31. Chen, Y-N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J., and Fojo, A. T. Characterization of Adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J. Biol. Chem., 265: 10073-10080, 1990.